1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7078)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22470)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10530)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (298)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
    Journal Article

    Hudis, C.; Swanton, C.; Janjigian, Y. Y.; Lee, R.; Sutherland, S.; Lehman, R.; Chandarlapaty, S.; Hamilton, N.; Gajria, D.; Knowles, J.; more...
    Breast Cancer Research (2013)

    Fulltext@MSK | Save
  • Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture
    Journal Article

    Awong, G.; Singh, J.; Mohtashami, M.; Malm, M.; La Motte-Mohs, R. N.; Benveniste, P. M.; Serra, P.; Herer, E.; Van Den Brink, M. R.; Zuniga-Pflucker, J. C.
    Blood (2013)

    Fulltext@MSK | Save
  • Phase II trial of the phosphatidyinositol-3 kinase (Pi3k) inhibitor buparlisib (Bkm120) in recurrent glioblastoma: An Ivy Foundation early phase clinical trials consortium study
    Meeting Abstract

    Wen, P.; Yung, A.; Mellinghoff, I.; Lamborn, K.; Ramkissoon, S.; Cloughesy, T.; Rinne, M.; Omuro, A.; DeAngelis, L.; Gilbert, M.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Evaluation of H3K27ME3 and EZH2 in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant GBM
    Meeting Abstract

    Venneti, S.; Garimella, M.; Sullivan, L.; Martinez, D.; Huse, J.; Heguy, A.; Santi, M.; Thompson, C.; Judkins, A.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Glioma-associated IDH mutation induces miR-34a repression and stem cell-like physiology through enhanced PDGF signaling
    Meeting Abstract

    Silber, J.; Harinath, G.; Aldaz, B.; Fabius, A. W. M.; Turcan, S.; Chan, T. A.; Huse, J. T.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Axitinib radiosensitization of radiosurgery
    Meeting Abstract

    Rao, S.; Thompson, C.; Cheng, J.; Haimovitz-Friedman, A.; Fuks, Z.; Kolesnick, R.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • ABC2 Award Abstract: Origins of metastatic traits
    Meeting Abstract

    Massague, J.
    Breast (2013)

    Fulltext@MSK | Save
  • Transduction susceptibility and engraftment potential of genetically-modified human thalassemic CD34+cells collected by different mobilization approaches
    Meeting Abstract

    Karponi, G.; Psatha, N.; Zogas, N.; Zervou, F.; Tsatalas, K.; Sadelain, M.; Riviere, I.; Anagnostopoulos, A.; Stamatoyannopoulos, G.; Yannaki, E.
    Human Gene Therapy (2013)

    Fulltext@MSK | Save
  • Therapeutically targeting ATRX deficiency in lower-grade astrocytoma
    Meeting Abstract

    Aldaz, B.; Fabius, A. W. M.; Silber, J.; Harinath, G.; Chan, T. A.; Huse, J. T.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Combined nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab in the treatment of advanced melanoma (MEL) patients (pts): Safety and clinical activity
    Meeting Abstract

    Sznol, M.; Callahan, M. K.; Kluger, H.; Postow, M. A.; Burke, M.; Hong, Q.; Selby, M.; Korman, A.; Gupta, A.; Wolchok, J. D.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save